Symbols / REVB Stock $1.17 +1.53% Revelation Biosciences, Inc.
REVB (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
- Revelation Biosciences trades new 5-year warrants for $11M cash - Stock Titan Fri, 23 Jan 2026 08
- REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year - Stocktwits Mon, 26 Jan 2026 17
- Revelation Biosciences to implement 1-for-4 reverse stock split - Investing.com Mon, 26 Jan 2026 08
- REVB Revelation Biosciences posts massive Q4 2025 EPS shortfall on zero revenue, shares remain unchanged. - Operational Risk - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - newswire.com Fri, 23 Jan 2026 08
- REVB (Revelation Biosciences Inc.) posts drastically wider than expected Q4 2025 loss, sending its stock down 4.76% in today’s trading. - EBITDA Margin - Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 19
- Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering - Yahoo Finance hu, 29 May 2025 07
- Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025 - Business Wire ue, 01 Jul 2025 07
- Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance - Stock Titan hu, 19 Mar 2026 07
- Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap - Investing.com hu, 19 Mar 2026 07
- REVB (Revelation Biosciences Inc.) falls 4.58% today after Q4 2025 EPS misses estimates by a staggering 541.5%. - UBND thành phố Hải Phòng Wed, 22 Apr 2026 21
- Can Revelation Biosciences (REVB) Stock Reach New Highs | Price at $1.19, Up 1.70% - Fast Rising Stocks - Cổng thông tin điện tử tỉnh Tây Ninh Sat, 28 Mar 2026 07
- Kidney injury trial draws 5 specialists to guide Revelation study - Stock Titan Mon, 06 Apr 2026 07
- FDA, Revelation map single trial for deadly kidney injury drug - Stock Titan Wed, 21 Jan 2026 08
- Revelation Biosciences' Roth fireside chat streams live at 2 p.m. PT - Stock Titan ue, 24 Mar 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
9.07
+13.74%
|
7.98
-7.87%
|
8.66
-20.32%
|
10.86
|
| Research And Development |
|
4.06
+14.51%
|
3.55
-14.40%
|
4.15
-22.90%
|
5.38
|
| Selling General And Administration |
|
5.01
+13.12%
|
4.43
-1.88%
|
4.51
-17.79%
|
5.49
|
| General And Administrative Expense |
|
5.01
+13.12%
|
4.43
-1.88%
|
4.51
-17.79%
|
5.49
|
| Salaries And Wages |
|
3.05
+10.02%
|
2.77
+21.86%
|
2.27
+21.19%
|
1.87
|
| Other Gand A |
|
1.96
+18.31%
|
1.66
-25.96%
|
2.24
-38.03%
|
3.61
|
| Total Expenses |
|
9.07
+13.74%
|
7.98
-7.87%
|
8.66
-20.32%
|
10.86
|
| Operating Income |
|
-9.07
-13.74%
|
-7.98
+7.87%
|
-8.66
+20.32%
|
-10.86
|
| Total Operating Income As Reported |
|
-9.07
-13.74%
|
-7.98
+7.87%
|
-8.66
+20.32%
|
-10.86
|
| EBITDA |
|
-9.04
-13.80%
|
-7.95
+7.93%
|
-8.63
+20.37%
|
-10.84
|
| Normalized EBITDA |
|
-9.05
-12.67%
|
-8.03
+52.66%
|
-16.96
-56.47%
|
-10.84
|
| Reconciled Depreciation |
|
0.03
-3.10%
|
0.03
+11.47%
|
0.03
+0.00%
|
0.03
|
| EBIT |
|
-9.07
-13.74%
|
-7.98
+7.87%
|
-8.66
+20.32%
|
-10.86
|
| Total Unusual Items |
|
0.00
-97.35%
|
0.08
-99.02%
|
8.33
|
—
|
| Total Unusual Items Excluding Goodwill |
|
0.00
-97.35%
|
0.08
-99.02%
|
8.33
|
—
|
| Net Income |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Pretax Income |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Other Income Expense |
|
0.16
+102.23%
|
-7.06
-182.74%
|
8.54
+24316.25%
|
0.03
|
| Other Non Operating Income Expenses |
|
0.16
+102.17%
|
-7.14
-3543.76%
|
0.21
+493.42%
|
0.03
|
| Gain On Sale Of Security |
|
0.00
-97.35%
|
0.08
-99.02%
|
8.33
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Net Income From Continuing Operation Net Minority Interest |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Net Income From Continuing And Discontinued Operation |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Net Income Continuous Operations |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Normalized Income |
|
-8.92
+41.03%
|
-15.12
-78.95%
|
-8.45
+21.98%
|
-10.83
|
| Net Income Common Stockholders |
|
-14.87
+1.15%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Otherunder Preferred Stock Dividend |
|
5.95
|
0.00
|
—
|
—
|
| Diluted EPS |
|
-23.95
+97.72%
|
-1,052.16
-938.86%
|
-101.28
+99.89%
|
-91,775.84
|
| Basic EPS |
|
-23.95
+97.72%
|
-1,052.16
-938.86%
|
-101.28
+99.89%
|
-91,775.84
|
| Basic Average Shares |
|
0.62
+4243.58%
|
0.01
+1104.04%
|
0.00
+905.93%
|
0.00
|
| Diluted Average Shares |
|
0.62
+4243.58%
|
0.01
+1104.04%
|
0.00
+905.93%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-14.87
+1.15%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
11.58
+74.91%
|
6.62
-45.78%
|
12.21
+121.91%
|
5.50
|
| Current Assets |
|
10.81
+64.67%
|
6.57
-45.95%
|
12.15
+124.40%
|
5.41
|
| Cash Cash Equivalents And Short Term Investments |
|
10.70
+64.65%
|
6.50
-45.80%
|
11.99
+128.28%
|
5.25
|
| Cash And Cash Equivalents |
|
10.70
+64.65%
|
6.50
-45.80%
|
11.99
+128.28%
|
5.25
|
| Prepaid Assets |
|
0.08
+349.76%
|
0.02
-68.85%
|
0.06
|
0.00
|
| Current Deferred Assets |
|
—
|
0.00
-100.00%
|
0.07
-18.40%
|
0.09
|
| Other Current Assets |
|
0.03
-31.42%
|
0.05
+67.94%
|
0.03
-59.69%
|
0.07
|
| Total Non Current Assets |
|
0.77
+1269.20%
|
0.06
-13.45%
|
0.07
-27.79%
|
0.09
|
| Net PPE |
|
0.74
+1214.27%
|
0.06
-13.45%
|
0.07
-27.79%
|
0.09
|
| Gross PPE |
|
0.84
+455.36%
|
0.15
+14.53%
|
0.13
+0.00%
|
0.13
|
| Accumulated Depreciation |
|
-0.10
-4.42%
|
-0.09
-41.75%
|
-0.07
-59.88%
|
-0.04
|
| Other Properties |
|
0.84
+455.36%
|
0.15
+14.53%
|
0.13
+0.00%
|
0.13
|
| Other Non Current Assets |
|
0.03
|
—
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
2.72
+42.24%
|
1.91
-65.61%
|
5.56
+25.03%
|
4.45
|
| Current Liabilities |
|
2.00
+4.42%
|
1.91
-65.61%
|
5.56
+25.03%
|
4.45
|
| Payables And Accrued Expenses |
|
1.98
+3.21%
|
1.91
-23.83%
|
2.51
+63.17%
|
1.54
|
| Payables |
|
0.58
-26.30%
|
0.78
-42.38%
|
1.36
+145.38%
|
0.55
|
| Accounts Payable |
|
0.58
-26.30%
|
0.78
-42.38%
|
1.36
+145.38%
|
0.55
|
| Current Accrued Expenses |
|
1.40
+23.68%
|
1.13
-1.94%
|
1.15
+16.94%
|
0.99
|
| Current Debt And Capital Lease Obligation |
|
0.02
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.02
|
0.00
|
—
|
0.00
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
2.91
+0.00%
|
2.91
|
| Other Current Liabilities |
|
—
|
0.00
-98.41%
|
0.14
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.72
|
0.00
|
0.00
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.72
|
0.00
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
0.72
|
0.00
|
—
|
—
|
| Stockholders Equity |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Common Stock Equity |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Capital Stock |
|
0.00
+3500.00%
|
0.00
+175.00%
|
0.00
-79.22%
|
0.00
|
| Common Stock |
|
0.00
+3500.00%
|
0.00
+175.00%
|
0.00
-79.22%
|
0.00
|
| Preferred Stock |
|
—
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
1.58
+3539.80%
|
0.04
+3060.35%
|
0.00
+1066.95%
|
0.00
|
| Ordinary Shares Number |
|
1.58
+3539.80%
|
0.04
+3060.35%
|
0.00
+1066.95%
|
0.00
|
| Additional Paid In Capital |
|
58.28
+28.90%
|
45.21
+40.79%
|
32.11
+21.65%
|
26.40
|
| Retained Earnings |
|
-49.42
-22.01%
|
-40.51
-59.05%
|
-25.47
-0.47%
|
-25.35
|
| Total Equity Gross Minority Interest |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Total Capitalization |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Working Capital |
|
8.81
+89.45%
|
4.65
-29.33%
|
6.58
+584.04%
|
0.96
|
| Invested Capital |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Total Debt |
|
0.75
|
0.00
|
—
|
0.00
|
| Capital Lease Obligations |
|
0.75
|
0.00
|
—
|
0.00
|
| Net Tangible Assets |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Tangible Book Value |
|
8.86
+88.20%
|
4.71
-29.17%
|
6.65
+531.64%
|
1.05
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-8.27
+54.86%
|
-18.32
-151.45%
|
-7.29
+35.06%
|
-11.22
|
| Cash Flow From Continuing Operating Activities |
|
-8.27
+54.86%
|
-18.32
-151.45%
|
-7.29
+35.06%
|
-11.22
|
| Net Income From Continuing Operations |
|
-8.91
+40.73%
|
-15.04
-12405.64%
|
-0.12
+98.89%
|
-10.83
|
| Depreciation Amortization Depletion |
|
0.03
-3.10%
|
0.03
+11.47%
|
0.03
+0.00%
|
0.03
|
| Depreciation |
|
0.03
-3.10%
|
0.03
+11.47%
|
0.03
+0.00%
|
0.03
|
| Depreciation And Amortization |
|
0.03
-3.10%
|
0.03
+11.47%
|
0.03
+0.00%
|
0.03
|
| Other Non Cash Items |
|
0.02
-25.48%
|
0.03
|
—
|
0.01
|
| Stock Based Compensation |
|
0.60
+252.60%
|
0.17
+8.43%
|
0.16
-48.29%
|
0.30
|
| Operating Gains Losses |
|
0.01
+111.11%
|
-0.08
+99.02%
|
-8.33
|
—
|
| Gain Loss On Investment Securities |
|
-0.00
+97.35%
|
-0.08
+99.02%
|
-8.33
|
—
|
| Gain Loss On Sale Of PPE |
|
0.01
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-0.01
+99.82%
|
-3.42
-448.53%
|
0.98
+234.36%
|
-0.73
|
| Change In Prepaid Assets |
|
-0.04
-347.88%
|
0.02
+255.65%
|
-0.01
-102.03%
|
0.57
|
| Change In Payables And Accrued Expense |
|
0.06
+101.81%
|
-3.51
-485.27%
|
0.91
+174.59%
|
-1.22
|
| Change In Accrued Expense |
|
0.27
+109.19%
|
-2.94
-1912.71%
|
0.16
+129.13%
|
-0.56
|
| Change In Payable |
|
-0.21
+64.23%
|
-0.58
-176.87%
|
0.75
+212.55%
|
-0.67
|
| Change In Account Payable |
|
-0.21
+64.23%
|
-0.58
-176.87%
|
0.75
+212.55%
|
-0.67
|
| Change In Other Working Capital |
|
—
|
0.07
-13.33%
|
0.08
+234.20%
|
-0.06
|
| Change In Other Current Assets |
|
-0.03
|
0.00
|
—
|
—
|
| Change In Other Current Liabilities |
|
0.01
|
0.00
|
0.00
+100.00%
|
-0.02
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Capital Expenditure |
|
—
|
-0.02
|
—
|
—
|
| Financing Cash Flow |
|
12.47
-2.93%
|
12.85
-8.39%
|
14.03
-7.72%
|
15.20
|
| Cash Flow From Continuing Financing Activities |
|
12.47
-2.93%
|
12.85
-8.39%
|
14.03
-7.72%
|
15.20
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-0.80
|
| Issuance Of Debt |
|
—
|
—
|
0.00
-100.00%
|
2.50
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-3.30
|
| Short Term Debt Issuance |
|
—
|
—
|
0.00
-100.00%
|
2.50
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-3.30
|
| Net Short Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-0.80
|
| Net Common Stock Issuance |
|
3.39
-37.45%
|
5.42
-61.39%
|
14.03
+215.21%
|
4.45
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-0.01
|
—
|
| Proceeds From Stock Option Exercised |
|
9.08
+22.23%
|
7.43
+21854932.35%
|
0.00
-99.33%
|
0.01
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
11.53
|
| Changes In Cash |
|
4.20
+176.49%
|
-5.49
-181.51%
|
6.74
+69.39%
|
3.98
|
| Beginning Cash Position |
|
6.50
-45.80%
|
11.99
+128.28%
|
5.25
+312.09%
|
1.27
|
| End Cash Position |
|
10.70
+64.65%
|
6.50
-45.80%
|
11.99
+128.28%
|
5.25
|
| Free Cash Flow |
|
-8.27
+54.91%
|
-18.34
-151.71%
|
-7.29
+35.06%
|
-11.22
|
| Change In Interest Payable |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Common Stock Issuance |
|
3.39
-37.45%
|
5.42
-61.39%
|
14.03
+215.21%
|
4.45
|
| Issuance Of Capital Stock |
|
3.39
-37.45%
|
5.42
-61.39%
|
14.03
+214.85%
|
4.46
|
| Net Preferred Stock Issuance |
|
—
|
0.00
+100.00%
|
-0.01
-200.00%
|
0.01
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.01
|
| Preferred Stock Payments |
|
—
|
0.00
+100.00%
|
-0.01
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-19 View
- 8-K2026-02-26 View
- 10-K2026-02-26 View
- 42026-02-05 View
- 42026-02-05 View
- 42026-02-05 View
- 42026-02-05 View
- 42026-02-05 View
- 8-K2026-01-29 View
- 8-K2026-01-22 View
- 42026-01-12 View
- 42026-01-12 View
- 42026-01-12 View
- 42026-01-12 View
- 42026-01-12 View
- 8-K2025-12-03 View
- 8-K2025-11-06 View
- 10-Q2025-11-06 View
- 42025-10-31 View
- 42025-10-31 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|